Replies to post #32212 on Marker Therapeutics Inc (MRKR)

[Buckboard]

Thanks

[microcapbiotech]

Once again Phantom, Thanks for both your answers. CAR-T being approved makes sense. And the CD19 toxicity to healthy cells also makes complete sense.

[GoIrish1776]

Easier path to approval…unless there is something about people who fail CART that means they will fail here too. The BCM data goes out the window if we have a different treatment group. Anyway, we are a long way from something interesting and a lot of dilution. Still hoping for the best.